InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
+79.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Glessner Coleen, VP Exécutif. Director active across 1 company, notably Emergent BioSolutions Inc.. In total, 14 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €525k. Activity tracked since 8 April 2022. The latest transaction was disclosed on 7 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
30,608 shares@ US$10.0050.0% of flowCommon StockSEC:0001919170-25-000004
30,608 shares@ US$10.000.064% mcap50.0% of flowCommon StockSEC:0001919170-25-000004:0
480 shares@ US$4.440.3% of flowCommon StockSEC:0001367644-25-000092:0
62,500 shares0Common StockSEC:0001367644-25-000047:0
5,913 shares0Common StockSEC:0001367644-25-000034:0
18,674 shares@ US$9.0122.8% of flowCommon StockSEC:0001367644-24-000191:0
1,249 shares@ US$6.191.0% of flowCommon StockSEC:0001367644-24-000106:0
585 shares@ US$2.290.2% of flowCommon StockSEC:0001367644-24-000049:0
381 shares@ US$3.390.2% of flowCommon StockSEC:0001367644-24-000024:0
15,385 shares0Common StockSEC:0001367644-23-000124:0
480 shares0Common StockSEC:0001367644-23-000080:0
3,846 shares0Common StockSEC:0001367644-23-000070:0
24,078 shares0Common StockSEC:0001367644-22-000156:0
5,913 shares0Common StockSEC:0001367644-22-000063:0
14 of 14 declarations
About Glessner Coleen
Coleen Glessner is the Executive Vice President of Quality and Ethics at Emergent BioSolutions Inc. She oversees the company's quality and ethics initiatives, ensuring compliance and integrity in operations. Her role is crucial for Emergent's reputation.
